share_log

Clover Health | 10-Q: Q3 2024 Earnings Report

Clover Health | 10-Q: Q3 2024 Earnings Report

Clover Health | 10-Q:2024財年三季報
美股SEC公告 ·  2024/11/08 21:14

牛牛AI助理已提取核心訊息

Clover Health reported strong Q3 2024 financial results with total revenue increasing 8.2% to $331 million, driven by a 7.1% rise in premiums earned to $322.6 million. The company significantly narrowed its net loss to $9.2 million from $41.5 million in Q3 2023, while maintaining a stable medical care ratio of 78.0%.The company demonstrated improved operational efficiency with a 9.2% reduction in salaries and benefits to $55.0 million and a 14.2% decrease in general and administrative expenses to $35.2 million. Other income grew 75.2% to $8.4 million, benefiting from higher interest rates. The Insurance segment served 81,110 Medicare Advantage members across five states.Notable developments include CMS increasing Clover's PPO Medicare Advantage plans rating to 4 Stars for 2025, which will enable a 5% quality bonus increase in benchmark rates for 2026. The company also launched Counterpart Health, a new SaaS solution to extend its AI-powered care management platform to external Medicare Advantage payors and providers.
Clover Health reported strong Q3 2024 financial results with total revenue increasing 8.2% to $331 million, driven by a 7.1% rise in premiums earned to $322.6 million. The company significantly narrowed its net loss to $9.2 million from $41.5 million in Q3 2023, while maintaining a stable medical care ratio of 78.0%.The company demonstrated improved operational efficiency with a 9.2% reduction in salaries and benefits to $55.0 million and a 14.2% decrease in general and administrative expenses to $35.2 million. Other income grew 75.2% to $8.4 million, benefiting from higher interest rates. The Insurance segment served 81,110 Medicare Advantage members across five states.Notable developments include CMS increasing Clover's PPO Medicare Advantage plans rating to 4 Stars for 2025, which will enable a 5% quality bonus increase in benchmark rates for 2026. The company also launched Counterpart Health, a new SaaS solution to extend its AI-powered care management platform to external Medicare Advantage payors and providers.
Clover Health在2024年第三季度報告了強勁的財務業績,總營業收入增長了8.2%,達到了33100萬,主要得益於保費收入增長了7.1%,達到了32260萬。公司顯著縮小了淨虧損,從2023年第三季度的4150萬降至920萬,同時保持了穩定的醫療保健比率爲78.0%。公司展現了提高的運營效率,薪資和福利下降了9.2%,降至5500萬,管理費用下降了14.2%,降至3520萬。其他收入增長了75.2%,達到了840萬,受益於更高的利率期貨。保險部門在五個州服務了81,110名醫療保險優先計劃成員。值得注意的發展包括CMS將Clover的PPO醫療保險優先計劃評級提高到2025年的4星,這將使得2026年的基準費率質量獎金增加5%。公司還推出了Counterpart Health,這是一種新的Saas-雲計算解決方案,旨在將其基於人工智能的護理管理平台擴展到外部醫療保險優先支付者和提供者。
Clover Health在2024年第三季度報告了強勁的財務業績,總營業收入增長了8.2%,達到了33100萬,主要得益於保費收入增長了7.1%,達到了32260萬。公司顯著縮小了淨虧損,從2023年第三季度的4150萬降至920萬,同時保持了穩定的醫療保健比率爲78.0%。公司展現了提高的運營效率,薪資和福利下降了9.2%,降至5500萬,管理費用下降了14.2%,降至3520萬。其他收入增長了75.2%,達到了840萬,受益於更高的利率期貨。保險部門在五個州服務了81,110名醫療保險優先計劃成員。值得注意的發展包括CMS將Clover的PPO醫療保險優先計劃評級提高到2025年的4星,這將使得2026年的基準費率質量獎金增加5%。公司還推出了Counterpart Health,這是一種新的Saas-雲計算解決方案,旨在將其基於人工智能的護理管理平台擴展到外部醫療保險優先支付者和提供者。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。